BAC - Bank Of America Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Bank Of America Corporation (BAC)

Other Ticker:

Sector • Financial Industry • Money Center Banks

Industry • Money Center Banks

Sector • Financial

Price: $24.1900 $0.17

0.708%

Day's High:	$24.51	Week Perf:	5.13 %
Day's Low:	$ 23.98	30 Day Perf:	1.09 %
Volume (M):	12,348	52 Wk High:	$ 35.72
Volume (M$):	$ 296,905	52 Wk Avg:	$28.46
Open:	$22.71	52 Wk Low:	$17.95

BAC Charts & Quotes

BAC Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	214,389
Shares Outstanding (Millions)	8,863
Employees	224,000
Revenues (TTM) (Millions $)	87,417
Net Income (TTM) (Millions $)	24,129
Cash Flow (TTM) (Millions $)	72,986
Capital Exp. (TTM) (Millions $)	0

Bank Of America Corporation
Bank of America Corporation is a Delaware corporation, a bank holding company and a financial holding company under the Gramm-Leach-Bliley Act. The principal executive offices of the Corporation are located in the Bank of America Corporate Center, Charlotte, North Carolina 28255.

Company Address: 100 N. Tryon Street Charlotte 28255 NC
Company Phone Number: 386-5681 Stock Exchange / Ticker: NYSE BAC

BAC is expected to report next financial results on July 15, 2020.

Next quarterly dividend payout on September 28, 2020.

Bank Of America's Segments


Consumer Banking	Segment	35.46 %	of total Revenue
Asset Management	Segment	29.35 %	of total Revenue
Global Banking	Segment	18.97 %	of total Revenue
Global Markets	Segment	18.43 %	of total Revenue
Commercial & Investment	Segment	37.41 %	of total Revenue
Other	Segment	-2.22 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Bank Of America does not provide revenue guidance. • Earnings Outlook Bank Of America Corporation does not provide earnings estimates.

Geographic Revenue Dispersion
U.S.	86.6 %
Asia	4.28 %
EMEA	7.61 %
Latin America	1.51 %

Bank Of America's Operating Statistics		Decrease / Increase

Interest rate Spread	1.88	-17.18 %
Interest margin	2.10		-
Nonperforming Assets Ratio	1.44	-10.56 %
Allowance for Credit Losses	1.44	-15.79 %
Tier1 Capital Ratio	12.90		0 %
Total Capital Ratio	15.80		0 %
Leverage Ratio	8.50		7.59 %
Tangible Common Equity Ratio	8.76		9.16 %
Efficiency Ratio	66.76	-28.28 %
• View Complete Report

News

Remedent Inc

Remedent Inc announced fourth quarter operating loss of $-0.192893 millions

In the fourth quarter Remedent Inc posted a loss of $-0.02 per share compared to $0.13 a year ago and increased losses from $-0.01 per share from the previous quarter.

Sales faded by -38.03% to $0.25 millions from $0.40 millions in the same quarter a year ago and sequentially Sales decreased by -4.49% from $0.26 millions.

Acura Pharmaceuticals Inc

Company Fail to Break-even Despite Surge in Sales

Acura Pharmaceuticals Inc announced very strong Sales growth of 1528.36% year on year to $1.09 millions in the first quarter, but lost money at $-0.02.

Smg Industries Inc

Company Fail to Break-even Despite Surge in Sales

Smg Industries Inc announced very strong Sales growth of 240.98% year on year to $5.98 millions in the first quarter, but increased losses at $-0.19.

Bionik Laboratories Corp

Bionik Laboratories Corp announced fourth quarter operating shortfall of $-2.338606 millions

In the fourth quarter Bionik Laboratories Corp reached break-even of $0.00 per share compared to $0.00 a year ago and from $-0.58 per share from the previous quarter.

Sales crumbled by -27.15% to $0.92 millions from $1.27 millions in the same quarter a year ago and sequentially Sales doubled by 484.34 % from $0.16 millions.

Biohitech Global Inc

Losses Widen, Sales very Strong

In the first quarter Biohitech Global Inc increased losses of $-0.16 per share compared to $-0.14 a year ago and increased losses from $-0.14 per share from the previous quarter.

Sales grew strongly by 84.27% to $1.36 millions from $0.74 millions in the same quarter a year ago and sequentially Sales surged by 35.42 % from $1.00 millions.

BAC's Valuation	Current
Price to Earnings PE Ratio (TTM)	9.90
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	2.45
Price to Sales (Expected)	-
Price to Book	0.81
PEG (TTM)	-

BAC's Financial Strength	Current
Quick Ratio	0.23
Working Capital Ratio	0.77
Leverage Ratio (MRQ)	8.89
Total Debt to Equity	1.08
Interest Coverage (TTM)	2.5
Debt Coverage (TTM)	0.19

Per Share	Current
Earnings (TTM)	2.44 $
Revenues (TTM)	9.86 $
Cash Flow (TTM)	8.24 $
Cash	53.69 $
Book Value	29.89 $
Dividend (TTM)	0.67 $

BAC's Efficiency	Current
Revenue per Employee (TTM)	390,254
Net Income per Employee (TTM)	107,719
Receivable Turnover Ratio (TTM)	-
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.04

BAC's Profitability Ratio	Current
Gross Margin	61.44 %
Operating Margin	40.81 %
Net Margin	17.61 %
Net Cash Flow Margin	390.17 %
Effective Tax Rate (TTM)	15.39 %

Management Effectiveness	Current
Return On Assets (TTM)	1.06 %
Return On Investment (TTM)	4.71 %
Return On Equity (TTM)	9.02 %
Dividend Yield	3.89 %
Payout Ratio (TTM)	27.42 %

BAC's Valuation
Price to Earnings PE Ratio (TTM)	9.90
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	2.45
Price to Sales (Expected)	-
Price to Book	0.81
PEG (TTM)	-

BAC's Financial Strength
Quick Ratio	0.23
Working Capital Ratio	0.77
Leverage Ratio (MRQ)	8.89
Total Debt to Equity	1.08
Interest Coverage (TTM)	2.5
Debt Coverage (TTM)	0.19

Per Share
Earnings (TTM)	2.44 $
Revenues (TTM)	9.86 $
Cash Flow (TTM)	8.24 $
Cash	53.69 $
Book Value	29.89 $
Dividend (TTM)	0.67 $

• View Valuation Comparisons

• View Growth Rates Comparisons

BAC's Efficiency
Revenue per Employee (TTM)	390,254
Net Income per Employee (TTM)	107,719
Receivable Turnover Ratio (TTM)	-
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.04

BAC's Profitability Ratio
Gross Margin	61.44 %
Operating Margin	40.81 %
Net Margin	17.61 %
Net Cash Flow Margin	390.17 %
Effective Tax Rate (TTM)	15.39 %

Management Effectiveness
Return On Assets (TTM)	1.06 %
Return On Investment (TTM)	4.71 %
Return On Equity (TTM)	9.02 %
Dividend Yield	3.89 %
Payout Ratio (TTM)	27.42 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income fell by	BAC's customers Net margin fell to 17.61 %
-69.39 %	2.86 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

JPM		2.79%
NMR	-100%
FITB	-0.85%
COF	-1.74%
C		0.44%
USB		0%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar LM's Profile Stock Price LM's Financials Business Description Fundamentals Charts & Quotes LM's News Suppliers LM's Competitors Customers & Markets Economic Indicators LM's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

BAC Company Profile

Remedent Inc announced fourth quarter operating loss of $-0.192893 millions

Company Fail to Break-even Despite Surge in Sales

Company Fail to Break-even Despite Surge in Sales

Bionik Laboratories Corp announced fourth quarter operating shortfall of $-2.338606 millions

Losses Widen, Sales very Strong